1,611 followers
The initial QT concern arose from pharmacoepidemiological (database) studies finding an association with serious ventricular arrhythmia/sudden cardiac death (RFs: >60 years old; dose >30mg/24h; concurrent CYP3A4 inhibitor or another QT prolonger) …